HLB Pep Co., Ltd. — Investor Relations & Filings
Filings indexed
276
across all filing types
Latest filing
2025-02-04
Regulatory Filings
Country
KR
South Korea
Listing
KO
196300
HLB Pep Co., Ltd. is a biopharmaceutical company specializing in the research, development, and production of peptide-based biomaterials and new drugs. The company's core activities include the manufacturing of peptide Active Pharmaceutical Ingredients (APIs) in a GMP-certified facility. It offers a range of products and services, including generic peptides, custom peptide synthesis for research and development, and a catalog of approximately 1,000 research peptides such as hormones and neuropeptides. HLB Pep focuses on discovering new drug candidates and aims to commercialize them through technology transfer.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 주권매매거래정지 (관리종목지정우려) | 2025-02-04 | Korean | |
| 내부결산시점관리종목지정ㆍ형식적상장폐지ㆍ상장적격성실질심사사유발생 | 2025-02-04 | Korean | |
| [기재정정]주요사항보고서(유상증자결정) | 2025-01-15 | Korean | |
| [기재정정]주요사항보고서(유상증자결정) | 2024-12-30 | Korean | |
| [기재정정]주요사항보고서(유상증자결정) | 2024-12-26 | Korean | |
| 주요사항보고서(유상증자결정) | 2024-12-20 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
3 filings
| |||||
| 7987938 | 주권매매거래정지 (관리종목지정우려) | 2025-02-04 | Korean | ||
| 7987937 | 내부결산시점관리종목지정ㆍ형식적상장폐지ㆍ상장적격성실질심사사유발생 | 2025-02-04 | Korean | ||
| 7991938 | [기재정정]주요사항보고서(유상증자결정) | 2025-01-15 | Korean | ||
|
2024
12 filings
| |||||
| 7998883 | [기재정정]주요사항보고서(유상증자결정) | 2024-12-30 | Korean | ||
| 8000162 | [기재정정]주요사항보고서(유상증자결정) | 2024-12-26 | Korean | ||
| 8001423 | 주요사항보고서(유상증자결정) | 2024-12-20 | Korean | ||
| 8002146 | [기재정정]단일판매ㆍ공급계약체결 | 2024-12-19 | Korean | ||
| 8003602 | 주주명부폐쇄기간또는기준일설정 | 2024-12-16 | Korean | ||
| 8015134 | 분기보고서 (2024.09) | 2024-11-14 | Korean | ||
| 8046973 | 투자판단관련주요경영사항 (가니렐릭스 원료의약품 미국식품의약국(FDA) 품목허가 신청) | 2024-10-21 | Korean | ||
| 8079966 | 소송등의판결ㆍ결정 | 2024-09-05 | Korean | ||
| 8080440 | 소송등의제기ㆍ신청(경영권분쟁소송) (주주총회소집허가) | 2024-09-04 | Korean | ||
| 8090828 | 반기보고서 (2024.06) | 2024-08-14 | Korean | ||
| 8110274 | 주식등의대량보유상황보고서(일반) | 2024-07-11 | Korean | ||
| 8112230 | 임시주주총회결과 | 2024-07-05 | Korean | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
HLB Pep Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/17556/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=17556 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=17556 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=17556 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 17556}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for HLB Pep Co., Ltd. (id: 17556)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.